Telekom Malaysia app streamlines prescriptions for pharmacies

Telekom Malaysia app streamlines prescriptions for pharmacies

Telekom Malaysia’s enterprise unit, Unifi Business, says it has launched an “e-Pharmacy” mobile application that it says enables e-prescriptions via teleconsultation for pharmacists and their walk-in patients.

Developed in collaboration with local telemedicine platform Teleme Technologies, the e-Pharmacy app includes access to over 500 licensed healthcare professionals for teleconsultation, e-prescriptions, customised Digital Signature, e-health articles and a repository for patients’ medical records.

TM says the app aims to help pharmacists dispense essential medications and pharmaceutical services, especially among rural and underserved communities, via e-prescriptions that enable seamless access to prescribed medications.

The e-Pharmacy offering is bundled with Unifi Business’ fixed broadband plans from 100 Mbps to 2 Gbps. TM says that under the Malaysian government’s Geran Digital PMKS Madani (GDPM), eligible MSME pharmacies will be entitled to claim rebates up to 50% discounts off Unifi Business’ commercial package price for 12 months. The GDPM aims to help MSMEs receive government support to embrace digitalisation.

“By integrating connectivity and technologies into patient care, our e-Pharmacy solution aims to support healthcare professionals and the government in providing efficient and beneficial services for all Malaysians, especially among communities where healthcare access remains a challenge,” said TM group CEO Amar Huzaimi Md Deris in a statement.

MORE ARTICLES YOU MAY BE INTERESTED IN...


Sign-up to our weekly newsletter

Keep up-to-date with all the latest news, articles, event and product updates posted on Developing Telecoms.
Subscribe to our FREE weekly email newsletters for the latest telecom info in developing and emerging markets globally.
Sending occasional e-mail from 3rd parties about industry white papers, online and live events relevant to subscribers helps us fund this website and free weekly newsletter. We never sell your personal data. Click here to view our privacy policy.